Pieris offering expected to raise $22.7 million

A public US share offering of Pieris Pharmaceuticals Inc (formerly Pieris AG) has been priced at $2.75 per share for the 9,090,909 shares on offer, giving net proceeds of $22.7 million, a figure that could rise if over-allotments are exercised.